Renal responses to the kappa-opioid-receptor agonist U-50488H in conscious lambs

Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R162-8. doi: 10.1152/ajpregu.00863.2006. Epub 2007 Apr 4.

Abstract

In adult animals and humans, activation of kappa-opioid receptors results in a diuresis. The aim of the present study was to investigate whether kappa-opioids are also diuretic early in life and whether this is altered during postnatal maturation. Therefore, the renal effects of the kappa-opioid-receptor agonist U-50488H were measured in two separate age groups of conscious lambs at two stages of postnatal maturation (approximately 1 wk and approximately 6 wk) under physiological conditions. To evaluate whether the renal responses to U-50488H resulted from receptor-dependent effects, responses to U-50488H were also tested in the presence of the specific kappa-opioid-receptor antagonist 5'-guanidinonaltrindole (GNTI). Urinary flow rate, free water clearance, and electrolyte excretions and clearances were measured for 30 min before and for 90 min after intravenous injection of U-50488H or vehicle. An increase in urinary flow rate accompanied by an increase in free water clearance occurred in response to administration of U-50488H but not vehicle. There were no effects of U-50488H on electrolyte excretions or clearances at either 1 or 6 wk of postnatal life. Although there were no effects of GNTI on any of the measured or calculated variables, the aforementioned diuretic response to U-50488H was abolished by pretreatment with GNTI in both age groups. We conclude that kappa-opioid receptors are diuretic early in life and that this response does not appear to be altered as postnatal maturation proceeds. Therefore, these data provide evidence that activation of kappa-opioid receptors early in life may lead to alterations in fluid balance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / pharmacology*
  • Aging / physiology
  • Analgesics, Non-Narcotic / pharmacology*
  • Animals
  • Animals, Newborn
  • Diuresis / drug effects
  • Dose-Response Relationship, Drug
  • Electrolytes / urine
  • Guanidines / pharmacology
  • Kidney / drug effects*
  • Kidney / growth & development
  • Naltrexone / analogs & derivatives
  • Naltrexone / pharmacology
  • Receptors, Opioid, kappa / agonists*
  • Receptors, Opioid, kappa / antagonists & inhibitors
  • Sheep
  • Urodynamics / physiology

Substances

  • 6'-guanidinonaltrindole
  • Analgesics, Non-Narcotic
  • Electrolytes
  • Guanidines
  • Receptors, Opioid, kappa
  • Naltrexone
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer